In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Medtechs Fear That Pre-COVID-19 Activity May Be Over A Year Away

Long Waiting Lists And Patients' Reluctance To Present For Cancer And Other Care Are Compounding An Already Difficult Situation

Executive Summary

Top of the agenda for the medtech industry globally is when the “new normal” will return. In the UK, the expectations are that post-COVID-19 health care activity will increase gradually, but it is possible that the National Health Service will not reach its pre-coronavirus capacities until late in 2021, “if at all.”

You may also be interested in...



Germany’s Digital Hospital Funding Ambitions Take Shape In Speedy Draft Law Process

A short comment period for Germany’s future hospital financing bill will be followed by parliamentary debate before it becomes law.

COVID-19: UK NHS Chief Calls For 90% Return To Planned Care Within 3 Months

The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.

Germany’s ‘Future Hospitals’ Draft Law Needs Sharp Focus On Digital And Robotics Investment

Hospital administrators and clinicians in Germany seek enhanced digitization of clinical procedures, but the budgets have not always been available. A new “future hospitals investment” program, now made into a draft law, should reserve funds for robotics and digital health care.

Topics

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel